International Stem Cell Corp. (ISCO) Expands Focus on Parkinson’s Disease via Clinical Research Agreement
International Stem Cell Corp., a California-based biotechnology company developing novel stem cell-based therapies, announced this morning that it has entered into a master clinical research agreement with Duke University to conduct clinical trials research in Parkinson's disease using ISCO's innovative neural stem cell product. Mark Stacy, M.D., Vice Dean for Clinical Research, Neurology at Duke University School of Medicine and an internationally recognized leader in the field of Movement Disorders, including Parkinson's disease, will be the study's primary investigator. The research will be coordinated by the Duke Clinical Research Institute (DCRI), the world's largest academic clinical research organization, which is…